Baseline observations from the POSSIBLE EU® study: Characteristics of postmenopausal women receiving bone loss medications

Archives of Osteoporosis

Volumn 5, Issue 1-2, 2010, Pages 61-72

  Freemantle, Nick ^m   Cooper, Cyrus ^a,b   Roux, Christian ^c   Díez Pérez, Adolfo ^d   Guillemin, Francis ^e   Jonsson, Bengt ^f   Ortolani, Sergio ^g   Pfeilschifter, Johannes ^h   Horne, Rob ⁱ   Kakad, Shilpa ^j   Shepherd, Susan ^j   Möller, Gerd ^k   Marciniak, Anne ^j   Martinez, Luc ^l  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^e UNIVERSITÉ DE LORRAINE   (France)

^f STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

^g ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^h ALFRIED KRUPP KRANKENHAUS   (Germany)

ⁱ UNIVERSITY OF LONDON   (United Kingdom)

^j AMGEN LTD   (United Kingdom)

^k AMGEN INC   (United States)

^l Societe Francaise de Medecine Generale   (France)

^m NONE

more..

Author keywords

Cohort studies; Osteoporosis; Postmenopausal osteoporosis; Prospective studies

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CLODRONIC ACID; ETIDRONIC ACID; FLUOROPHOSPHATE; HYDROXYAPATITE; IBANDRONIC ACID; NERIDRONIC ACID; PAMIDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; ZOLEDRONIC ACID;

AGED; ARTICLE; BONE DENSITY; BONE FRAGILITY; BONE MASS; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRANCE; GENERAL PRACTITIONER; GERMANY; HUMAN; ITALY; MAJOR CLINICAL STUDY; OSTEOLYSIS; OUTCOME ASSESSMENT; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SPAIN; UNITED KINGDOM;

EID: 79451470635     PISSN: 18623522     EISSN: 18623514     Source Type: Journal    
DOI: 10.1007/s11657-010-0035-7     Document Type: Article

References (20)

1. ES Siris JP Bilezikian MR Rubin, et al. 2003 Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures J Clin Endocrinol Metab 88 3482 3486 1:CAS:528:DC%2BD3sXmsFOks7c%3D 10.1210/jc.2003-030568 12915621 (Pubitemid 37034480)
2. C Roux K Briot S Horlait A Varbanov NB Watts S Boonen 2007 Assessment of non-vertebral fracture risk in postmenopausal women Ann Rheum Dis 66 931 935 10.1136/ard.2006.064071 17314119 (Pubitemid 46999796)
3. International Osteoporosis Foundation (2008) Osteoporosis in the European Union in 2008: ten years of progress and ongoing challenges. Available at http://www.iofbonehealth.org/publications/eu-policy-report-of-2008.html. Accessed 8 April 2009
4. E Seeman J Compston J Adachi, et al. 2007 Non-compliance: the Achilles' heel of anti-fracture efficacy Osteoporosis Int 18 711 719 1:STN:280: DC%2BD2s3mt1Sksg%3D%3D 10.1007/s00198-006-0294-8 (Pubitemid 46684777)
5. JA Kanis N Burlet C Cooper, et al. 2008 European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 19 399 428 1:STN:280:DC%2BD1c3itFekuw%3D%3D 10.1007/s00198-008-0560-z 18266020
6. E Barrett-Connor K Ensrud A Tosteson, et al. 2009 Design of the POSSIBLE US™ study: postmenopausal women's compliance and persistence with osteoporosis medications Osteoporosis Int 20 463 472 1:STN:280: DC%2BD1M7jtlSnsA%3D%3D 10.1007/s00198-008-0674-3
7. R Brooks 1996 EuroQol: the current state of play Health Policy 37 53 72 1:STN:280:DyaK283otFKhsg%3D%3D 10.1016/0168-8510(96)00822-6 10158943 (Pubitemid 26191458)
8. The EuroQol Group 1990 EuroQol-a new facility for the measurement of health-related quality of life Health Policy 16 199 208 10.1016/0168-8510(90) 90421-9
9. EuroQol Group EQ-5D. In. EuroQol Group Rotterdam, The Netherlands
10. S Silverman 2000 The Osteoporosis Assessment Questionnaire (OPAQ): a reliable and valid disease-targeted measure of health-related quality of life (HRQOL) in osteoporosis Qual Life Res 9 767 774 10.1023/A:1008934208764
11. Guideline for prevention and treatment of Op SINOSSI. Available at http://www.siommms.it. Last accessed 12 March 2009
12. Agence Francaise de Securite Sanitaire des Produits de Sante. Available at http://www.afssaps.fr/var/afssaps-site/storage/original/application/ 2f4831c7ee9d9bd6fda336a26b6500c6.pdf Last accessed 17 April 2009
13. Evidenz-basierte Konsensus-Leitlinien zur Osteporose (2009) Available at http://www.dv-osteologie.org/. Last accessed 17 April
14. National Institute for Health and Clinical Excellence (NICE) (2009) Available at http://www.nice.org.uk/guidance/index.jsp?action=byID&r= true&o=11621. Last accessed 14 April
15. Sociedad Española de Investigaciones Óseas y Metabolismo Mineral - SEIOMM (2009) Available at http://www.seiomm.org/documentos/ osteoporosis-es-en.pdf. Last accessed 14 April
16. Lindsay R, Delmas P, Boonen S, Diez-Perez A, Dedrick R, Saag KG (2008) Regional differences in the management of osteoporosis in women. ASBMR abstract book 2008. SU287
17. F Jakob F Marín E Martin-Mola, et al. 2006 Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO) QJM 99 531 543 1:STN:280:DC%2BD28vlslKjtQ%3D%3D 10.1093/qjmed/hcl073 16861718 (Pubitemid 44304838)
18. E Sornay-Rendu F Munoz P Garnero F Duboeuf PD Delmas 2005 Identification of osteopenic women at high risk of fracture: the OFELY study J Bone Miner Res 20 1813 1819 10.1359/JBMR.050609 16160738 (Pubitemid 41361882)
19. A Díez-Pérez J González-Macías F Marín, et al. 2007 Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound Osteoporos Int 18 629 639 10.1007/s00198-006-0297-5 17235664 (Pubitemid 46525547)
20. S Adami G Isaia G Luisetto, et al. 2008 Osteoporosis treatment and fracture incidence: the ICARO longitudinal study Osteoporos Int 19 1219 1223 1:CAS:528:DC%2BD1cXotV2iu78%3D 10.1007/s00198-008-0566-6 18286217